Company profile
ArcoScreen SA
ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology enables the prediction of a drug’s efficacy rapidly and early in the drug discovery process (lead optimization and mode of action identification) before expensive clinical trials. Our mission is to revolutionize drug discovery to improve patients’ lives.
Source: startup.ch
More news about ArcoScreen SA
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
